Enzo Biochem Inc. v. Applera Corp., No. 14-1321 (Fed. Cir. Mar. 16, 2015)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

This appeal arises from the judgment of the United States District Court for the District of Connecticut following a jury trial on issues of infringement and inv a- lidity of U.S. Patent 5,449,767 (“’767 patent”). The Plai n- tiffs, Enzo Biochem Inc., Enzo Life Sciences, Inc., and Yale University (collectively “Enzo”), asserted claims 1, 8, 67, 68, and 70 of the ’767 patent against the Defendant Applera Corp. and Tropix, Inc. (“Applera”).